The most likely explanation relates to Mounjaro's effect on gastric motility and delayed gastric emptying
Here is who benefits most: Good fit if you: Qualify for GLP-1 medication (BMI 30+ or BMI 27+ with a weight-related condition) Want behavioral coaching alongside medication, not just a prescription Prefer a structured program with lessons, food logging, and community support Have tried medication alone and struggled with side effects or regain Want compounded medication shipped to your door (avoiding pharmacy visits) Not a good fit if you: Want the cheapest way to get a GLP-1 prescription (Ro and similar services are less expensive for medication-only access) Already have strong nutrition habits and just need the drug Live in Alabama, Louisiana, Mississippi, or Virginia (some programs unavailable) Have a history of medullary thyroid cancer, multiple endocrine neoplasia 2, or active gastrointestinal conditions like gastroparesis Want brand-name medication but do not have insurance to cover it (the out-of-pocket drug cost makes it very expensive) How Noom Med Compares to Alternatives The GLP-1 telehealth space has gotten crowded
Some emerging research suggests GLP-1 receptor agonists may have anti-inflammatory properties that could benefit gum health, particularly in people with type 2 diabetes
No cortisol or prolactin elevation
You eat because you need to, not because you are driven by compulsive hunger
Cravings for high-calorie foods may reappear
